FindTrial
Sign In

Feasibility of remote parameters testing based on 5G cloud technology support platform in pacemaker implantations: a single-center, randomized, open-label, parallel-design trial

Feasibility of remote parameters testing based on 5G cloud technology support platform in pacemaker implantations: a single-center, randomized, open-label, parallel-design trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052627
Enrollment
Unknown
Registered
2021-11-02
Start date
2021-10-29
Completion date
Unknown
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia

Interventions

Experimental group:Remote parameters testing in pacemakers implantation
The control group:Traditional parameter testing in pacemakers implantation

Sponsors

Third People's Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. St. Jude single-chamber and dual-chamber pacemaker implantation patients; 3. Those who signed the informed consent.

Exclusion criteria

Exclusion criteria: Patients with the slowest ventricular rate < 30 beats per minute before implantation.

Design outcomes

Primary

MeasureTime frame
Radiation dose and duration;The operation time;Signal interruption and problems about the screen;Satisfaction with the use of remote parameters testing;—

Secondary

MeasureTime frame
frequency of opening the door;The frequency and total duration of the parameters test;—

Countries

China

Contacts

Public ContactCai Lin

Third People's Hospital of Chengdu

clin63@hotmail.com+86 13808018627

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026